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Objective: To study the self-medication for pain among students of medicine and nursing of 
the PUCSP compared with students from other knowledge areas. 
Material and methods: Data were obtained in two groups: A - students from the health knowl-
edge area, and B - students of law and engineering. It was used a questionnaire developed 
by the authors. Statistical analysis used the Chi-square test and the Fischer. 
Results: In relation to gender, there is a predominance of women in the health group and 
a male majority in other one. In the health group there was a greater number of medi-
cal students, and in the control group of engineering. It is observed a high degree of self-
treatment in both groups. It appears that participants in the health group have used more 
anti-inflammatory drugs and opioid than the others subjects studied. 
Conclusion: The frequency of medication for pain is higher in the group of health students, 
and self-medication is equally practiced among students of health and other areas.
 © 2014 Elsevier Editora Ltda. All rights reserved.
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Estudo da automedicação para dor musculoesquelética entre estudantes 
dos cursos de enfermagem e medicina da Pontifícia Universidade 
Católica - São Paulo
Palavras-chave:
Dor
Analgésicos
Automedicação
r e s u m o
Objetivo: Estudar a automedicação para dor entre estudantes de cursos de medicina e enfer-
magem da PUCSP em comparação com estudantes das outras áreas de conhecimento. 
Material e métodos: Esses dados foram obtidos em dois grupos: A – estudantes da área da 
saúde e B – estudantes da área de ciências humanas e exatas. Utilizou-se um questionário 
elaborado pelos autores. A análise estatística usou o teste do qui-quadrado e de Fischer. 
Resultados: Na área de saúde há um predomínio do gênero feminino, e nas outras áreas um 
predomínio masculino. Na área de saúde a maior parte dos estudantes cursa medicina, e 
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nas outras áreas engenharia. Observa-se um alto índice de automedicação em ambos os 
grupos, constatando-se que os participantes do grupo da área de saúde usam significativa-
mente mais opioides e anti-inflamatórios que os demais estudados. 
Conclusão: A frequência do uso de medicamentos para dor é maior no grupo de estudantes 
da área de saúde, e a automedicação é praticada igualmente entre estudantes da área de 
saúde e das demais áreas.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Pain is defined as “a sensory and emotional experience as-
sociated with existing or potential tissue damage, reported 
as if the injury already existed.” Pain is classified as acute or 
chronic. The occurrence of acute pain indicates injury and 
exhibits a physiological factor of defense. On the other hand, 
chronic pain in general has no physiological value and cor-
responds to an adaptation mechanism.1-4 Moreover, Woolf5 
divides pain in adaptive pain, associated with the protec-
tion of the body and with promotion of wound healing (noci-
ceptive and/or inflammatory origin), and maladaptive pain, 
which is related to pathological CNS activity (neuropathic 
and/or functional origin).
Pain should be treated with analgesics and non-pharma-
cological measures. Among these, we emphasize healthcare 
education, exercise, and physical medicine. According to 
Teixeira,4 physical medicine provides comfort, cures physi-
cal dysfunctions, normalizes physiological dysfunctions and 
reduces the fear associated with the mobilization or im-
mobilization of body parts. The modalities used in physical 
medicine are acupuncture, thermotherapy, massotherapy, 
mobilization, electroanalgesia and psicoprophylaxis (medi-
tation, hypnosis, relaxation, etc.).3,4,6
Pharmacological therapy is aimed at treating short-term 
pain, enabling the individual to achieve mobility.3,4 Analge-
sia obtained through drugs does not eliminate the cause of 
pain, but its proper use may lead to an improved quality of 
life since it facilitates the treatment of the causal factor, and 
possibly prevents the acute to chronic pain progression.4 The 
drugs used include analgesics, nonsteroidal anti-inflamma-
tory drugs (NSAIDs), opioids and possibly antidepressants 
and anticonvulsants as adjuvants.3-5,7-10 The indiscriminate 
use of these drugs should be avoided, because of its adverse 
effects. One of the central aspects regarding the appropri-
ate use of drugs involves self-medication. Arrais et al.11 re-
fer to self-medication as a procedure characterized by the 
initiative of a patient, or of his (hers) parents, to obtain or 
produc,e and use a product which, he (she) believes, will 
benefit the treatment of diseases or for relieving the symp-
toms.12 Another term used, according to Bestane et al.,13 is 
“oriented self-medication”, which refers to the reuse of old 
prescriptions not intended for continuous use.
Theoretically, healthcare professionals and students 
know the medications and their risks, so they should avoid 
self-medication. The aim of this study was to evaluate the 
proper use of pain medication for pain management by 
healthcare students, compared to students from other 
knowledge areas.
Material and methods
1) Patients: 247 medicine and nursing students at the Pon-
tifícia Universidade Católica de São Paulo (PUC-SP) were 
studied.
2) A control group of 252 law and engineering students was 
also studied.
3) Study Design: A cross-sectional descriptive cohort study.
4) Elaboration and application of a questionnaire containing 
the following variables: demographic data, student data, 
number of analgesics used in the last year, presence or 
absence of medical indication, incidence in both groups 
of drugs’, with and without prescription, adverse effects.
5) Statistical analysis: chi-square or Fisher’s exact test were 
applied (Siegel, 2006), aiming to compare groups A and B 
in relation to percentage of use, prescriptions obtained, 
appearance of adverse effects and type of drug used. The 
level of significance was p < 0.05%, or 5%.18
6) Ethical aspects: This project and the obtained informed 
consent were approved by the Ethics in Research Commit-
tee of Faculdade de Ciências Médicas e da Saúde, PUC-SP.
Results
Table 1 shows the distribution of subjects according to gen-
der, age and area of knowledge. Regarding gender, in group 
A (healthcare subjects) there is a predominance of females; 
in group B there is a male predominance. In group A, most 
students pertained to medicine area; in group B, there was a 
predominance of subjects in the engineering field. 
Table 2 shows the frequency and percentage of analgesics 
used in the last year. More individuals in group A used anal-
gesics, compared to group B.
Table 3 shows the origin of the pharmacological indication, 
with or without  prescription. A high rate of self-medication 
in both groups was observed, without statistically significant 
difference. 
Table 4 shows the frequency of reported adverse effects after 
the use of analgesics in both groups. There is a low incidence of 
adverse effects in both groups, without a statistically significant 
difference.
Table 5 shows the distribution of analgesics use in relation 
to pharmaceutical specialties. In group A, analgesics (45.5%) 
and anti-inflammatory drugs (55.3% ) intake was significantly 
higher than opioids (4.4%), and antidepressants (4.0%) con-
sumption. In group B (control), the chi-square test showed 
that analgesic consumption (43.2%) was significantly higher 
than all other drugs. This test also revealed that anti-inflam-
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matory drugs (23.0%) were more used than opioids (1.6%) and 
antidepressants (2.8%). Comparing the two groups, the statis-
tical analysis showed that the use of anti-inflammatory drugs 
in group A (55.3%) was significantly higher than the control 
group (23%). As well as with opioids, the results were not sig-
nificant, but suggest greater use in group A (4.4%). In relation 
to analgesics and antidepressant drugs, no significant differ-
ence between the two groups was observed.
Discussion
Self-medication can induce harmful consequences, regard-
less of disease, symptom or medication used. In the case of 
pain, this is even truer. The need for quick relief and the nega-
tive impact that pain causes in quality of life imply that the 
rate of self-medication in this area is quite notorious.
Analgesics and NSAIDs have a similar mechanism of ac-
tion; both are cyclooxygenase (COX) inhibitors. These en-
zymes are classified into: (1) COX-1, a constitutional enzyme 
expressed in most tissues including circulating platelets and 
is involved in tissue homeostasis; and (2) COX-2, induced by 
activated inflammatory cells (IL-1 and TNF-α-mediators), is 
responsible for the production of prostanoid mediators of 
inflammation, and it is also a CNS constitutive enzyme.7,9,10 
Recently the existence of COX-3 was described, but its actions 
are not yet fully understood.7,9 Analgesics exert their func-
tion mainly by inhibiting COX-2 by reducing the production 
of prostaglandins, bradykinins and serotonin, which are the 
main nociceptor stimulants, thus leading to analgesia.7,9
NSAIDs, however, have analgesic, antipyretic and an-
ti-inflammatory effects.7,9 The analgesic effect is similar 
to that quoted as the mechanism of action of analgesic 
drugs.7,9 The antipyretic effect is result of COX-2 inhibition 
in the central nervous system, which prevents the set point 
rise of the hypothalamic thermostat.7,9 Finally, the anti-
inflammatory effect occurs by COX inhibition which inter-
rupts the production and activation process of inflamma-
tory mediators.5,7,9,10
Both analgesics and NSAIDs have similar adverse effects, 
due to their mechanisms of action. For NSAIDs, these effects 
involve gastrointestinal disorders (dyspepsia, diarrhea, nau-
sea, vomiting, gastric ulceration and bleeding),7,9,10 allergic 
skin reactions7,9 and renal effects,7,9 (chronic nephritis, papil-
lary necrosis, and acute reversible renal insufficiency).
Table 1 – Demographics and area of activity data.
Variable Healthcare 
area
Other areas Total
Age m (SD) 22.35 (5.56) 22.08 (9.94) 22.09 (9.94)
Gender n (%)
Male 110 (42.6) 148 (57.4) 258 (100)
Female 137 (56.8) 104 (43.2) 241 (100)
Student area 
n (%)
Medicine 185 (74.9) 185 (37.1)
Nursing 
course
62 (25.1) 62 (12.4)
Law 121 (48.1) 121 (24.2)
Engineering 131 (51.9) 131 (26.3)
Total 247 (100) 252 (100) 499 (100)
Table 2 – Frequency of use of pain medication in the last 
year.
Groups Used n (%) Not used n (%) Total n (%)
Health 157 (63.8) 90 (36.2) 247 (100)
Other areas 119 (47.2) 133 (52.8) 252 (100)
Total 276 223 498
p < 0.0001.
Table 3 – Indication obtained by medical appointment, 
or not.
Prescription Yes n (%) No n (%) Total n (%)
Healthcare 63 (40.1) 94 (59.9) 157 (100)
Other areas 46 (38.6) 73 (61.4) 119 (100)
Total 109 155 264
p < 0.05 or no significant.
Table 4 – Frequency of adverse effects.
Prescription Yes n (%) No n (%) Total n (%)
Healthcare 25 (17.2) 120 (82.8) 145 (100)
Other areas 15 (12.6) 104 (87.4) 119 (100)
Total 40 224 264
p < 0.05 or no significant.
Table 5 – Distribution of drugs used according to pharmaceutical class.
Groups Healthcare Other p
Yes No % Yes Yes No  % Yes
Simple analgesics 113 135 45.56 109 143 43.2 > 0.05
Anti-inflammatory agents 145 117 55.34 58 194 23.0 < 0.01
Opioids 11 237 4.4 4 248 1.6 > 0.05
Antidepressives 10 238 4.0 7 245 2.8 > 0.05
Total 279 727 38.37 178 830 17.7
Observations:
Group A (healthcare) has 157 participants who used drugs. 
Group B (other areas) has 119 participants who used drugs. 
A participant may have used more than one drug.
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Drugs characterized as opioids are used as analgesic, an-
titussive and antidiarrheal agents.7,9 The opioid receptors are: 
μ (mu), κ (kappa) and δ (delta).7,9 Each of these receptors is 
involved with specific effects of opioids, and the μ and δ re-
ceptors have similar actions in the same regions.7,9 The an-
algesia is produced at central level through interaction with 
opioid receptors present in the CNS, because these have the 
ability to directly inhibit the ascending transmission of no-
ciceptive information coming from the dorsal horn of the 
spinal cord, and also have the ability to activate pain inhibi-
tory descending pathways.5,7,9 The interaction of receptors 
with their agonists leads to a reduction of cyclic-AMP (cAMP) 
within neurons, inhibiting the opening of calcium channels 
in the presynaptic neuron, thereby inhibiting the release of 
neurotransmitters.5,7,9 Moreover, the decrease of intracellular 
cAMP stimulates the opening of potassium channels in the 
postsynaptic neuron, causing a hyperpolarization that pre-
vents the passage of nerve impulses by the ascending noci-
ceptive pathway; thus, analgesia is produced.5,7,9 Furthermore, 
the μ/δ receptors produce analgesia within the descending 
circuits of pain control partly by removing the inhibition me-
diated by gamma-aminobutyric acid (GABA) neurons that 
project to the rostral ventromedial (RVM) part of medulla in 
the gray periaqueductal (PA) substance, as well as of neurons 
projecting from the RVM to the spinal cord.7 The modula-
tory effects of pain by κ agonists in the brain stem seem to 
antagonize the effects of μ receptor agonists.7,9 Opioid drugs 
can produce many adverse effects such as sedation, euphoria, 
dysphoria, constipation, nausea, vomiting, pruritus, dizziness 
and respiratory depression, along with causing tolerance and 
dependence.7,9
Antidepressant agents can be used as adjuvant medi-
cation in the treatment of pain.3,4,7-9 The classes of antide-
pressant agents used are: monoamine oxidase inhibitors 
(MAOIs), tricyclic antidepressants (TCAs) and selective sero-
tonin re-uptake inhibitors (SSRIs).7,9 MAOIs inhibit the action 
of the enzyme monoamine oxidase (MAO), which is respon-
sible for the degradation of monoamines (dopamine, nor-
epinephrine and serotonin, for instance), thereby maintain-
ing a high concentration of monoamines of inhibitory pain 
pathways in the synaptic cleft.7,9 TCAs and SSRIs decrease 
the neurotransmitter re-uptake in inhibitory pain pathways 
at the synaptic clefts, thus increasing the concentration of 
these peptides in the synapses and thereby increasing the 
stimulus in the postsynaptic neuron.7,9 Antidepressants in-
crease the efferent pathway of pain inhibition, producing 
analgesia.7,9 Furthermore, TCAs are weak agonists of μ opioid 
receptors, helping to obtain an analgesic effect.9 Antidepres-
sants can cause several adverse effects such as sedation, an-
ticholinergic effects (dry mouth, constipation, blurred vision, 
urinary retention, etc.), postural hypotension, convulsions, 
impotence, weight gain, liver damage (rare), nausea and agi-
tation.7-9 The analgesic effect of TCAs is well documented; 
however, the analgesia produced by the use of MAOIs and 
SSRIs needs further studies.8
The degree of knowledge on this topic can generate an 
awareness of the risk of self-medication but, on the other 
hand, can cause a false sense of security in the use of these 
drugs, since access to such information is more expressive. 
Although healthcare students have greater knowledge, it is 
known that even experienced professionals are cautious 
about the use and prescription of these medications.
Among lay population, Pereira et al.14 reported that 51% of 
drugs were indicated by mothers and 7.8% by fathers; 20.1% 
by pharmacy employees, 15.3% resulted from the use of old 
prescriptions for the child or other family member, and 1.8% 
by media influence. According to the article "Prevalence and 
factors associated with self-medication: results from the 
Bamburgh project",15 the 16 non-prescription drugs more 
commonly consumed by self-medication were analgesics/
antipyretics (47.6%), followed by drugs acting on the diges-
tive tract, that is, antispasmodics, antidiarrheals, and antac-
ids (8.5%); antibiotics or chemotherapeutic agents (6.2%) and 
vitamins, tonics or anti-anemic drugs (4.7%).
On the other hand, among healthcare professionals, Hem 
et al.,16 in a cohort  composed by young Norwegian doctors, 
found a prevalence of 54% between the fourth and fifth year 
after graduation; and among those who used drugs in the 
year prior to the interview, 90% were self-prescriptions. 
Now Tomasi et al.17 in their cross-sectional study found that 
47% of healthcare workers reported drug using in the last 
15 days, especially analgesics (27%), regardless of having, 
or not, a health problem. Moreover, these authors observed 
that self-medication was common practice since one fourth 
of the respondents stated that most drugs used had no pre-
scription. Also in this work, 43% of physicians reported self-
medication.
In our study the frequency of analgesic use was also sig-
nificant, and it occurred most often through self-medication. 
This is true for both groups. The group A used significantly 
more pain medication than the other students. One aspect 
that may have reinforced this habit was the low frequency of 
adverse effects experienced by the subjects.
The group A used proportionately more anti-inflamma-
tory and opioid drugs. We attribute this difference to the 
greater knowledge and access to these drugs, although they 
increase the risk of complications. 
We can conclude that the frequency of drug use for pain 
is higher in the group of healthcare students (group A), and 
self-medication is practiced equally among healthcare stu-
dents and group B.
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